(Q37049240)

17 August 2017

1 reference

title

The multifactorial character of the protective immunity induced by immunization with sporozoites (English)

1 reference

17 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

2 December 2022

author name string

F. Zavala

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1817293

2 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1817293

2 December 2022

publication date

1 October 1991

1 reference

full work available at URL

17 August 2017

https://api.elsevier.com/content/article/PII:0923249491901448?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

https://api.elsevier.com/content/article/PII:0923249491901448?httpAccept=text/plain

2 December 2022

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

2 December 2022

published in

Research in Immunology

1 reference

17 August 2017

volume

142

1 reference

17 August 2017

issue

8

1 reference

17 August 2017

page(s)

654-658

1 reference

Synthetic peptides from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium knowlesi recognize the human hepatoma cell line HepG2-A16 in vitro

17 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells

2 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites

2 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Peptide-primed CD4+ cells and malaria sporozoites

2 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon

2 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Expression of class I and class II major histocompatibility complex antigens on human hepatocytes

2 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

2 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Non-CS pre-erythrocytic protective antigens

2 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein

2 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Rationale for the development of an engineered sporozoite malaria vaccine

2 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

TNF inhibits malaria hepatic stages in vitro via synthesis of IL-6.

2 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells

2 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria

2 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

2 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax.

2 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

2 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Epitopes recognized by human T lymphocytes on malaria circumsporozoite protein

2 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria

2 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

CD4+ cytolytic T cell clone confers protection against murine malaria

2 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes

2 December 2022

31

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite

2 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Synthetic peptide vaccine confers protection against murine malaria

2 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

Major population differences in T cell response to a malaria sporozoite vaccine candidate

2 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/0923-2494(91)90144-8

2 December 2022

Identifiers

1 reference

17 August 2017

1 reference